Dr Kamlesh Sheth wins FPM’s Volunteer Award 2026
Posted on: Tuesday 30 June 2026
The FPM Volunteer Award is given to an individual in recognition of consistent and/or outstanding efforts and contributions that have helped the FPM to achieve excellence in our mission to advance the science and practice of pharmaceutical medicine. This year, Dr Kamlesh Sheth has been awarded this honour.
Dr Sheth commented:
Being awarded the FPM Volunteer Award is a profound honour. Throughout my career, the specialty of Pharmaceutical Medicine and the Faculty have provided me with invaluable opportunities – from working alongside a Nobel laureate to helping pioneer new treatment models for rare diseases. My motivation to volunteer has always been simple: to give back to a community that has shaped my professional identity, and a desire to make a tangible difference to the specialty and FPM.
While I have always contributed without expectation of recognition, it is deeply rewarding to receive this award, as it serves as a meaningful validation that my efforts have, in some way, made a difference, which is exactly what I set out to achieve. I am truly grateful to my colleagues, my nominators, FPM team and, most importantly, my family. I suspect they deserve a secondary award of their own for the many hours of ‘family time’ they generously allowed me to borrow for the Faculty.
About Dr Sheth
Dr Kamlesh Sheth is an international healthcare leader with more than 35 years of experience across clinical practice, pharmaceutical medicine, academic research, governance, education, entrepreneurship and patient advocacy. He has worked as a clinician, researcher, pharmaceutical executive, educator, board leader and has held senior leadership roles across the healthcare and life sciences sectors.
Dr Sheth has made longstanding voluntary contributions to the Faculty of Pharmaceutical Medicine, serving as an appraiser for GMC revalidation, on the PMST Course Quality Management Panel and Board of Examiners, as chair of a Faculty special interest network, as trustee and honorary treasurer, and through work on the Fellowship Award Committee, patient engagement forum, trainee committee, PMST SAC, external representation, and consultation and policy responses.
He has also held leadership roles in the British Association of Pharmaceutical Physicians and supported patient organisations and rare disease initiatives.
He is Chair of Bluedil International Ltd, Chair and Managing Director of PharmacoMedics Ltd, Executive Chair and General Manager of Doksy Ltd, Trustee and Treasurer of Beacon for Rare Diseases and Honorary Lecturer at King’s College London.
Throughout his career, Dr Sheth has been a passionate advocate for patient-centred healthcare. He has worked at the interface of industry, academia and patient organisations to help advance drug development and improve outcomes for patients, particularly rare diseases. He has had the privilege of contributing to initiatives that brought together clinical science, academia, industry and patient advocacy groups. He remains committed to mentoring future healthcare and life science leaders, strengthening the pharmaceutical medicine specialty, and bridging the gap between scientific discovery and patient benefit.
